Minerva Imaging is a scientifically driven CRO founded in 2011. Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development.
We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers.
Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.